Distinct virulence and azole resistance profiles of <i>Candida albicans</i> clinical isolates from patients with acute and recurrent vulvovaginal candidiasis

Candida albicans is the primary etiological agent of acute vulvovaginal candidiasis (AVVC) and its recurrent form (RVVC), conditions that differ in clinical presentation, inflammatory context, and response to antifungal therapy. Although virulence factors and antifungal resistance have been individually linked to disease severity, their integrated contribution to distinct clinical outcomes remains poorly defined. Here, we performed a comprehensive phenotypic characterization of 58 clinical C. albicans isolates recovered from women with AVVC (n = 25) or RVVC (n = 33), and C. albicans SC5314 was included for comparison. We assessed fungal dimorphism, cell surface hydrophobicity, biofilm-forming capacity (BFC), and the production of secreted aspartyl proteinases (SAP) and lipases (LIP). Antifungal susceptibility to azoles and other clinically relevant agents was determined using an automated system. Multivariate unsupervised analyses were applied to identify integrated virulence phenotypes. All clinical isolates exhibited efficient filamentation. AVVC isolates displayed enhanced adherence, biofilm metabolic activity, and LIP production, whereas RVVC isolates exhibited increased SAP activity and reduced BFC. Unsupervised clustering and UMAP analysis identified four virulence clusters, including profiles specifically associated with AVVC or RVVC, as well as mixed phenotypes. Notably, a high prevalence of azole resistance was observed in both groups, with resistance patterns aligning with specific virulence clusters. Collectively, these findings indicate that AVVC and RVVC are associated with distinct, niche-adapted C. albicans virulence programs that integrate enzymatic activity, biofilm traits, and antifungal resistance. This structured phenotypic heterogeneity provides a framework to reinterpret vulvovaginal candidiasis as a multifactorial and adaptive process with important implications for disease persistence and therapeutic failure.

Authors

Institutions

Publication Details

Journal
Medical Mycology
Published
2026-04-01
DOI
https://doi.org/10.1093/mmy/myag028
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distinct virulence and azole resistance profiles of Candida albicans clinical isolates from patients with acute and recurrent vulvovaginal candidiasis

María Soledad Miró, Pablo Iribarren, Clarisa Manzone-Rodríguez, Emilse Rodríguez et al.
Medical Mycology
Reproductive tract infections research
article

Distinct virulence and azole resistance profiles of Candida albicans clinical isolates from patients with acute and recurrent vulvovaginal candidiasis

María Soledad Miró, Pablo Iribarren, Clarisa Manzone-Rodríguez, Emilse Rodríguez, Fernando Riera, Paula Alejandra Icely, Juan Pablo Caeiro, Sofia Carla Angiolini, Claudia Elena Sotomayor, Claudio Abiega
article en

Abstract

Candida albicans is the primary etiological agent of acute vulvovaginal candidiasis (AVVC) and its recurrent form (RVVC), conditions that differ in clinical presentation, inflammatory context, and response to antifungal therapy. Although virulence factors and antifungal resistance have been individually linked to disease severity, their integrated contribution to distinct clinical outcomes remains poorly defined. Here, we performed a comprehensive phenotypic characterization of 58 clinical C. albicans isolates recovered from women with AVVC (n = 25) or RVVC (n = 33), and C. albicans SC5314 was included for comparison. We assessed fungal dimorphism, cell surface hydrophobicity, biofilm-forming capacity (BFC), and the production of secreted aspartyl proteinases (SAP) and lipases (LIP). Antifungal susceptibility to azoles and other clinically relevant agents was determined using an automated system. Multivariate unsupervised analyses were applied to identify integrated virulence phenotypes. All clinical isolates exhibited efficient filamentation. AVVC isolates displayed enhanced adherence, biofilm metabolic activity, and LIP production, whereas RVVC isolates exhibited increased SAP activity and reduced BFC. Unsupervised clustering and UMAP analysis identified four virulence clusters, including profiles specifically associated with AVVC or RVVC, as well as mixed phenotypes. Notably, a high prevalence of azole resistance was observed in both groups, with resistance patterns aligning with specific virulence clusters. Collectively, these findings indicate that AVVC and RVVC are associated with distinct, niche-adapted C. albicans virulence programs that integrate enzymatic activity, biofilm traits, and antifungal resistance. This structured phenotypic heterogeneity provides a framework to reinterpret vulvovaginal candidiasis as a multifactorial and adaptive process with important implications for disease persistence and therapeutic failure.

Medical MycologyVol. 64(4)
Centro Científico Tecnológico - Córdoba (AR), AltaMed (US), Hospital Privado (AR), Fundacion Allende (AR), Cordoba University (US)
Consejo Nacional de Investigaciones Científicas y Técnicas, Secretaria de Ciencia y Tecnología - Universidad Nacional de Córdoba, Agencia Nacional de Promoción Científica y Tecnológica, Secretaría de Ciencia y Técnica, Universidad Nacional de Río Cuarto, Fondo para la Investigación Científica y Tecnológica
Good health and well-being
Openalex Percentile: Top 31%
Reproductive tract infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.